# FDA 483 - Patricia Kropf MD - October 21, 2020

Source: https://www.globalkeysolutions.net/records/483/patricia-kropf-md/6e3d5408-62f1-4756-8792-bd43aba7d995

> FDA 483 for Patricia Kropf MD on October 21, 2020. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Patricia Kropf MD
- Inspection Date: 2020-10-21
- Product Type: drugs
- Office Name: Philadelphia District Office
- Summary: An FDA inspection of Patricia Kropf MD, a clinical investigator in Philadelphia, revealed one significant observation. The firm failed to conduct an investigation in accordance with the investigational plan, specifically regarding the administration of study drug to a subject. Another observation was removed during discussions with management.

## Related Officers

- [Joseph L. Despins](https://www.globalkeysolutions.net/people/joseph-l-despins/c84402a8-7ebb-45ab-b1b9-c43a143c5fb8)
- [Rochelle L. Cross](https://www.globalkeysolutions.net/people/rochelle-l-cross/a227de1b-8b3c-4345-8920-0da8bc77a9e9)

Company: https://www.globalkeysolutions.net/companies/patricia-kropf-md/452f2148-b8c1-4ea5-8d3a-07527f28ee53

Office: https://www.globalkeysolutions.net/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8